Literature DB >> 9484670

Anticytokeratins are a potential source of false-positive indirect immunofluorescence assays for C-ANCA.

J Streicher1, B Fabian, K Herkner, H Pointner, P M Bayer.   

Abstract

Antibodies to neutrophil cytoplasmic antigens (ANCA) targeted toward granule enzymes have been recognized as a valuable diagnostic tool in the detection of Wegener's granulomatosis and systemic vasculitides. However, the most commonly used method of detection, the indirect immunofluorescence assay, is prone to false-positive results due to antibodies of different pathological significance either targeted to, or cross-reacting with, similarly distributed epitopes. Using double immunofluorescence, the present study demonstrates that anticytokeratin antibodies are able to produce false-positive C-ANCA immunofluorescence assays. In addition, a case of natural appearance of cytokeratin-reactive antibodies causing a false-positive "pseudo-ANCA" staining pattern in a patient presenting with sepsis is reported. Since the expression of cytokeratins is almost exclusively confined to epithelial cells, the most plausible explanation for both phenomena is a crossreaction of anticytokeratin antibodies with granule associated epitopes. Due to the natural appearance of anticytokeratin antibodies in association with a variety of other pathologic entities, it is of crucial importance for the diagnostic significance of the C-ANCA immunofluorescence assay to exclude anticytokeratin caused false-positive results. It is shown that supplementary indirect immunofluorescence tests performed on cultured human epithelial cells readily distinguish anticytokeratin caused "pseudo-ANCA" from true C-ANCA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9484670      PMCID: PMC6807877          DOI: 10.1002/(sici)1098-2825(1998)12:1<54::aid-jcla9>3.0.co;2-j

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  43 in total

1.  Indirect immunofluorescence examination for IgG-ANCA in sera submitted for the 1st international workshop on ANCA, 1988.

Authors:  N Rasmussen; A Wiik
Journal:  APMIS Suppl       Date:  1989

Review 2.  The clinical relevance of ANCA in vasculitis.

Authors:  W L Gross; S Hauschild; N Mistry
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

Review 3.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

Review 4.  [Semi-invasive diffuse pulmonary aspergillosis with antineutrophil cytoplasmic antibodies. 2 cases].

Authors:  A M Milesi-Lecat; O Aumaitre; T Deusebis; P Kaufman; A Tridon; M Cambon; J C Marcheix
Journal:  Ann Med Interne (Paris)       Date:  1994

Review 5.  Anti-neutrophil cytoplasmic antibodies.

Authors:  U Specks; H A Homburger
Journal:  Mayo Clin Proc       Date:  1994-12       Impact factor: 7.616

6.  Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus.

Authors:  T Kobayashi; K Nakanishi; H Kajio; S Morinaga; T Sugimoto; T Murase; K Kosaka
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

7.  Anti-proteinase 3 antibodies, their characterization and disease associations.

Authors:  J G Jennings; L Chang; J A Savige
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

8.  "False positive" perinuclear and cytoplasmic anti-neutrophil cytoplasmic antibody results leading to misdiagnosis of Wegener's granulomatosis and/or microscopic polyarteritis.

Authors:  A Davenport
Journal:  Clin Nephrol       Date:  1992-03       Impact factor: 0.975

9.  Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern.

Authors:  M Segelmark; B Baslund; J Wieslander
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

10.  Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils.

Authors:  R Goldschmeding; C E van der Schoot; D ten Bokkel Huinink; C E Hack; M E van den Ende; C G Kallenberg; A E von dem Borne
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

View more
  3 in total

1.  Powering single-cell genomics to unravel circulating tumour cell subpopulations in non-small cell lung cancer patients.

Authors:  Emmanuel Acheampong; Michael Morici; Afaf Abed; Samantha Bowyer; Du-Bois Asante; Weitao Lin; Michael Millward; Elin S Gray; Aaron B Beasley
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-28       Impact factor: 4.322

2.  Label-free enumeration, collection and downstream cytological and cytogenetic analysis of circulating tumor cells.

Authors:  Manjima Dhar; Edward Pao; Corinne Renier; Derek E Go; James Che; Rosita Montoya; Rachel Conrad; Melissa Matsumoto; Kyra Heirich; Melanie Triboulet; Jianyu Rao; Stefanie S Jeffrey; Edward B Garon; Jonathan Goldman; Nagesh P Rao; Rajan Kulkarni; Elodie Sollier-Christen; Dino Di Carlo
Journal:  Sci Rep       Date:  2016-10-14       Impact factor: 4.379

3.  High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1.

Authors:  Jennifer L Schehr; Zachery D Schultz; Jay W Warrick; David J Guckenberger; Hannah M Pezzi; Jamie M Sperger; Erika Heninger; Anwaar Saeed; Ticiana Leal; Kara Mattox; Anne M Traynor; Toby C Campbell; Scott M Berry; David J Beebe; Joshua M Lang
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.